<code id='9FD12647BF'></code><style id='9FD12647BF'></style>
    • <acronym id='9FD12647BF'></acronym>
      <center id='9FD12647BF'><center id='9FD12647BF'><tfoot id='9FD12647BF'></tfoot></center><abbr id='9FD12647BF'><dir id='9FD12647BF'><tfoot id='9FD12647BF'></tfoot><noframes id='9FD12647BF'>

    • <optgroup id='9FD12647BF'><strike id='9FD12647BF'><sup id='9FD12647BF'></sup></strike><code id='9FD12647BF'></code></optgroup>
        1. <b id='9FD12647BF'><label id='9FD12647BF'><select id='9FD12647BF'><dt id='9FD12647BF'><span id='9FD12647BF'></span></dt></select></label></b><u id='9FD12647BF'></u>
          <i id='9FD12647BF'><strike id='9FD12647BF'><tt id='9FD12647BF'><pre id='9FD12647BF'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:hotspot    Page View:87

          Who polices algorithms? How would you name the first approved CRISPR medicine? And what pairs well with a biotech downturn?

          We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Casey Ross joins us to tell the bombshell story of how the nation’s largest health insurer used a computer algorithm to deny patient care and boost its profitability. Then, biotech veteran Michael Gilman calls in to offer a behind-the-scenes peek at what it’s like to be a startup CEO in this economic downturn — and which cocktail recipes help make it bearable. We also discuss a pioneering approval for a genome-editing medicine.

          advertisement

          For more on what we cover, here’s the UnitedHealth story; here’s more on the CRISPR approval; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

          Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

          And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

          advertisement

          knowledge

          How to save PrEP access — and even expand it
          How to save PrEP access — and even expand it

          UndertheAffordableCareAct,healthinsurersarerequiredtocoverallcostsassociatedwithpreventivecare—inclu

          read more
          Readout Newsletter: Geron, Novo Nordisk, WuXi updates
          Readout Newsletter: Geron, Novo Nordisk, WuXi updates

          KayanaSzymczakforSTATWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiote

          read more
          Drug repurposing or repositioning? The language matters
          Drug repurposing or repositioning? The language matters

          AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

          read more

          A letter from the executive editor: The 2023 STATUS List

          Aftermonthsofvigorousdeliberations,I’mthrilledtoannounceour2023STATUSList—thedefinitiverosterofleade